A Single-center, Placebo-controlled, Double-blind, Study to Evaluate the Effects of RM-131 on Colonic Motor Functions in Patients With Chronic Constipation
Phase of Trial: Phase I
Latest Information Update: 20 May 2015
Price : $35 *
At a glance
- Drugs Relamorelin (Primary)
- Indications Constipation
- Focus Therapeutic Use
- Sponsors Rhythm; Rhythm Pharmaceuticals
- 04 Mar 2015 Status changed from recruiting to completed as reported by ClinicalTrials.gov record.
- 23 Oct 2014 Status changed from 'active, no longer recruiting' to 'recruiting' as reported by ClinicalTrials.gov record.
- 15 Sep 2014 Status changed from not yet recruiting to active, no longer recruiting as reported by ClinicalTrials.gov.